CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Ferrous sulfate 325mg +1 moredrug
Likely dose
Ferrous sulfate 325mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01755455
NCT01755455N/ACompleted
CompareCT.gov

Iron Supplementation for the Hypoferremic Anemia of Cystic Fibrosis

Dartmouth-Hitchcock Medical Center·interventional·Posted Dec 24, 2012·Updated Mar 16, 2017

In Brief

A clinical study evaluating Ferrous sulfate 325mg and Placebo for Cystic Fibrosis and Anemia, Iron-Deficiency. Completed, enrolled 22 participants across 2 sites.

Detailed Summary

This study questions whether low-dose ferrous sulfate taken by mouth daily for 6 weeks increases hemoglobin concentration in adult subjects with cystic fibrosis and hypoferremic anemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis, Anemia, Iron-Deficiency
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 24, 2012
Enrollment StartJun 1, 2011
Primary CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 13.5 years ago

Interventions

Ferrous sulfate 325mgdrug

Ferrous sulfate 325mg tablet taken by mouth daily for 6 weeks

Placebodrug

Matching placebo capsule